ContraVir Pharmaceuticals Inc.

(CTRV) Trade

Symbol has changed to a new ticker symbol

(HEPA)

By |

Profile

ContraVir Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. The company focuses on developing two novel oral compounds to treat HBV infection. CRV431 is a cyclophilin inhibitor that targets specific isomerases that play an important role in protein folding in health and in disease. TXL is a nucleotide pro-drug of tenofovir that inhibits hepatitis B viral replication and targets the liver, the reservoir for the hepatitis B virus.

Contact Information

Website: www.contravir.com
Email: info@contravir.com
Main Phone: +1 732 902-4000
Address: 399 Thornall Street, First Floor
State: NJ
City / Town: Edison
Country: USA
Postal Code: 08837

Issuer Information

Exchange: NSC
CEO: Robert T. Foster
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

ContraVir Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. The company focuses on developing two novel oral compounds to treat HBV infection. CRV431 is a cyclophilin inhibitor that targets specific isomerases that play an important role in protein folding in health and in disease. TXL is a nucleotide pro-drug of tenofovir that inhibits hepatitis B viral replication and targets the liver, the reservoir for the hepatitis B virus.

Contact Information

Website: www.contravir.com
Email: info@contravir.com
Main Phone: +1 732 902-4000
Address: 399 Thornall Street, First Floor
State: NJ
City / Town: Edison
Country: USA
Postal Code: 08837

Issuer Information

Exchange: NSC
CEO: Robert T. Foster
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 8
Number of Buys 0 8
Number of Sells 0 0
Net Activity 0 834517
Last 10 Buys Shares
John Cavan 1,000
James Sapirstein 1,000
James Sapirstein 1,000
James Sapirstein 1,000
John P. Brancaccio 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/20/17 04/20/17 04/20/17 04/20/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 2